ID: ALA4093840

Max Phase: Preclinical

Molecular Formula: C31H30F3N7O3

Molecular Weight: 605.62

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)c(NC)n2)ccc1C

Standard InChI:  InChI=1S/C31H30F3N7O3/c1-5-26(42)39-24-15-22(12-10-17(24)2)38-30-36-16-23(27(35-4)41-30)29(44)40-25-14-21(11-9-18(25)3)37-28(43)19-7-6-8-20(13-19)31(32,33)34/h6-16H,5H2,1-4H3,(H,37,43)(H,39,42)(H,40,44)(H2,35,36,38,41)

Standard InChI Key:  BYCFKWQXKQNWSN-UHFFFAOYSA-N

Associated Targets(Human)

Tyrosine-protein kinase BMX 1995 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase ABL 18331 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Stem cell growth factor receptor 10667 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Platelet-derived growth factor receptor alpha 5682 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Platelet-derived growth factor receptor beta 5195 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase receptor FLT3 13481 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Epidermal growth factor receptor erbB1 33727 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase JAK3 8349 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase BLK 2498 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 4657 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 605.62Molecular Weight (Monoisotopic): 605.2362AlogP: 6.75#Rotatable Bonds: 9
Polar Surface Area: 137.14Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.79CX Basic pKa: 4.81CX LogP: 6.91CX LogD: 6.91
Aromatic Rings: 4Heavy Atoms: 44QED Weighted: 0.14Np Likeness Score: -1.60

References

1. Liang X, Lv F, Wang B, Yu K, Wu H, Qi Z, Jiang Z, Chen C, Wang A, Miao W, Wang W, Hu Z, Liu J, Liu X, Zhao Z, Wang L, Zhang S, Ye Z, Wang C, Ren T, Wang Y, Liu Q, Liu J..  (2017)  Discovery of 2-((3-Acrylamido-4-methylphenyl)amino)-N-(2-methyl-5-(3,4,5-trimethoxybenzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-BMX-078) as a Highly Potent and Selective Type II Irreversible Bone Marrow Kinase in the X Chromosome (BMX) Kinase Inhibitor.,  60  (5): [PMID:28140585] [10.1021/acs.jmedchem.6b01413]

Source